Case study 02

Expanding Healthcare Distribution Beyond Routine Pharmacy Sales

Building the commercial foundation for institutional, tender and broader healthcare-market business.

A distribution business that sells to retail pharmacies is not automatically a business that can supply a hospital. The demand is different, the buying process is different, and the qualifying requirements are different — and most of them have to be in place before the first opportunity can even be pursued. This case is about building that foundation.

Business DevelopmentMarket DevelopmentInstitutional BusinessCommercial Strategy

01
Retail pharmacy distribution
02
Clinics & healthcare facilities
03
Institutional & hospital supply
Tendered & contracted demand
one channel, then several
Problem
Revenue concentrated in one channel, with institutional and tendered healthcare demand commercially out of reach rather than merely unwon.
Approach
Segment the healthcare market, establish what each buyer type requires before it can buy, and build the capability, portfolio and positioning to meet it.
Commercial result
The groundwork required to pursue institutional healthcare opportunities, tenders and broader medical-supply business — stated as readiness, not as contracts won.
Role
Business development, market and customer development, tender readiness, commercial positioning.

The problem

Five ways it shows up

A healthcare distribution business needed revenue channels beyond traditional pharmacy distribution. The constraint was not effort or appetite — it was that the business was not yet in a position to be considered.

One channel carrying the whole business

Retail pharmacy distribution is a sound channel and a narrow base. Concentration is comfortable while conditions hold and difficult to correct quickly once they do not, because the alternatives take months of preparation to become available.

Institutional demand buys differently

A hospital or healthcare facility does not buy the way a pharmacy buys. The volumes, the specifications, the documentation, the lead times and the people who decide are all different, and a portfolio assembled for one does not simply transfer to the other.

Eligibility precedes opportunity

Much of institutional and tendered business is decided before any commercial conversation: registrations, documentation, product coverage, supply assurance, terms. A business that starts assembling these when the opportunity appears has already missed it.

The portfolio was shaped by the existing channel

A range built for retail demand will have gaps against institutional requirements — and carry lines that are irrelevant to them. Neither is visible until the market is segmented and the range is read against each segment.

The business was described, not positioned

Materials and conversations explained what the business does. An institutional buyer is asking a narrower question — whether this supplier can be relied on for this category, at this scale, under these terms — and that question was not being answered.

Why it mattered

Five dimensions

Market expansion in healthcare distribution is not a sales problem with a longer cycle. It is a capability problem with a sales outcome, and the two fail differently.

Institutional business is not won by pursuing it harder. It is won by being eligible before the opportunity arrives, and eligibility is built in advance or not at all.

Revenue concentration

A single channel means a single set of conditions decides the year. Diversification is a structural correction, not a growth initiative, and it has to be started before it is needed.

Qualification lead time

Registrations, approvals and documentation run on their own timetable. Every week of preparation not done in advance is a week subtracted from the opportunity window itself.

Portfolio fit

Bidding with an incomplete range against a requirement is a decision to lose slowly. What the segment actually requires has to shape the portfolio before anything is submitted.

Supply credibility

Institutional buyers are buying continuity as much as product. A supplier who cannot evidence assurance of supply is carrying a disadvantage no price can offset.

Commercial positioning

Where a business is not clearly positioned for a segment, it is assessed against the segment it is known for — and found, accurately, to be something else.

My role

My role was to build the commercial foundation: understand where the demand sits, establish what it requires, and put the business in a position to pursue it credibly.

Segmented the healthcare market

Separated the buyer types the business could realistically serve — by how they buy, what they require and what a supplier must hold before they will consider one — rather than by how they are commonly grouped.

Developed institutional opportunities

Identified where institutional and facility demand was reachable, what would qualify the business for it, and which opportunities were worth the preparation they would take.

Built tender readiness

Established what has to exist before a submission is possible at all — documentation, product coverage, supply assurance, commercial terms — and worked to close the gaps ahead of the opportunity rather than against its deadline.

Developed customers and partners

Worked on the customer side and the supply side together, since the portfolio a segment requires and the partners who can supply it are the same problem approached from two directions.

Positioned the portfolio

Read the range against each segment’s requirements to show where it already fitted, where it had gaps worth closing, and where it did not belong and should not be offered.

Rebuilt the commercial materials

Reworked how the business presents itself so it answers the buyer’s question — capability, category coverage, reliability and terms — instead of describing the company.

Where the demand sits

Four buyer types

The segmentation is the foundation everything else rests on, because each buyer type imposes different requirements on the supplier — and those requirements, not the sales effort, decide whether the business is eligible.

Described by category deliberately. No institution, facility, customer or tender is named anywhere on this page, and none will be added.

What readiness required

Six areas of work

Readiness is not a state of mind — it is a list of things that either exist or do not on the day an opportunity appears. These are the areas the work concentrated on.

Customer & market development

Building reach into segments the business had not previously served, and relationships that exist before there is something to bid for rather than after.

Institutional opportunity development

Finding where institutional demand was genuinely addressable, and being honest about where it was not yet — which is the judgement that keeps preparation from being spent on the wrong openings.

Tender readiness

Assembling what a submission requires in advance: documentation, category coverage, supply assurance and commercial terms that can be committed to rather than improvised.

Supplier & partner development

Securing the supply side for categories the business intended to offer, since a commitment to an institutional buyer is only as good as what stands behind it.

Portfolio positioning

Aligning what the business carries with what each segment requires — closing the gaps worth closing and declining the categories it could not credibly serve.

Capability & positioning materials

Presenting the business as a supplier to a segment rather than as a company with a history: what it covers, at what scale, with what assurance and on what terms.

Where the contest is actually decided

In institutional healthcare supply, most of the competition happens before the opportunity is announced.

The visible contest is the submission. The decisive one is whether a supplier was eligible, credible and positioned months earlier — which is why this work is business development rather than selling.

Prepare against the requirement, not the deadline

Every qualifying element assembled in advance is one that is not being improvised under time pressure, when it will be assembled worse and read as such.

Decline what cannot be served

Pursuing a segment the business cannot supply reliably costs more than the opportunity is worth. Choosing the segments carefully is part of the strategy, not a retreat from it.

Supply assurance is the product

Institutional buyers are purchasing continuity. The commercial case is built on what the business can guarantee over time, not on what it can offer once.

Position for the buyer’s question

A buyer is deciding whether this supplier can be relied on for this category at this scale. Materials that answer anything else are answering a question nobody asked.

Outcome

Readiness, stated precisely

Stated as readiness and capability, which is what the work produced. No tender, contract, customer or figure is claimed — none has been supplied for publication, and readiness is a real outcome that does not need inflating.

The market was mapped rather than assumed. Buyer types were separated by how they buy and what they require, giving the business a basis for deciding which segments to pursue and which to leave.

Institutional opportunities became addressable. What had been a category the business was not eligible for became a set of specific requirements with owners and a sequence for closing them.

Tender submission became possible in principle. The qualifying elements a submission depends on were identified and progressed ahead of any opportunity, rather than assembled against a closing date.

The portfolio was read against demand. Gaps worth closing were separated from categories the business should not offer, so range decisions followed the market rather than the existing channel.

The business could describe itself to an institutional buyer. Positioning and materials answer the capability, coverage, reliability and terms question directly — the question an institutional buyer is actually asking.

This case describes commercial groundwork and readiness. It does not claim an awarded tender, a secured contract, a named customer or a revenue outcome, and nothing on this page should be read as claiming one.

What this demonstrates

Business development in healthcare is less about persuasion than about eligibility — understanding what a buyer requires, and building it before the conversation starts.

This case is the commercial counterpart to the operational ones. The same method runs underneath it: understand how the thing actually works, find where the business is losing — here, losing access rather than losing money — and build what closes the gap.

The healthcare knowledge is what makes it work. Knowing how facilities order, what continuity means to a pharmacy department and why a specification is written the way it is, is the difference between developing a market and approaching it.

Market understanding Capability building Positioning Commercial readiness

Growth here came from making the business eligible for demand it could already have served — which is usually a cheaper and more durable expansion than pursuing demand harder.

This case study describes commercial and market-development work. No organisation, customer, hospital, clinic, supplier, principal, brand, tender, price, commercial term or figure appears, and the environment is described by category and country only. Buyer types are described as categories rather than as counterparties. No awarded tender, contract or revenue outcome is claimed.

Contact

Is the business eligible for the demand it wants?

If institutional or tendered healthcare business keeps arriving too late to prepare for — and the qualifying work starts when the opportunity does — describe the position now. I'll tell you what I'd build first.